Evaluating drug-eluting stents in everyday clinical practice
Prospective Evaluation of Drug-Eluting Stents in Routine Clinical Practice
Asan Medical Center · NCT01788592
This study is testing how well drug-eluting stents work and their safety for people with coronary artery disease in everyday medical settings.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 50000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Asan Medical Center (other) |
| Locations | 1 site (Seoul) |
| Trial ID | NCT01788592 on ClinicalTrials.gov |
What this trial studies
This study aims to assess the effectiveness and safety of drug-eluting stent implantation for patients with coronary artery disease in routine clinical settings. By observing real-world outcomes, the study seeks to provide insights into how these stents perform outside of controlled trial environments. The observational nature of the study allows for a comprehensive evaluation of patient responses and potential complications associated with the stents.
Who should consider this trial
Good fit: Ideal candidates include patients with coronary artery disease who are eligible for percutaneous coronary intervention without any clinical or lesion limitations.
Not a fit: Patients with terminal illnesses, those experiencing cardiogenic shock, or those requiring a mix of different drug-eluting stents may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the understanding of drug-eluting stents' effectiveness, leading to improved treatment strategies for coronary artery disease.
How similar studies have performed: Other studies evaluating drug-eluting stents in real-world settings have shown promising results, indicating that this approach is supported by previous findings.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * coronary disease amenable to percutaneous coronary intervention (PCI) * no clinical and lesion limitations Exclusion Criteria: * patients with a mixture of several drug eluting stents * terminal illness with life expectancy less than 1 year * patients with cardiogenic shock
Where this trial is running
Seoul
- Asan Medical Center — Seoul, South Korea (RECRUITING)
Study contacts
- Principal investigator: Seung-Jung Park, MD, PhD — Asan Medical Center
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Coronary Artery Disease, coronary artery disease, drug eluting stent